• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前瞻性验证将骨髓炎添加到糖尿病足感染的中度和重度类别中的价值。

Prospective Validation of the Value of Adding Osteomyelitis to Moderate and Severe Categories of Diabetic Foot Infections.

机构信息

Department of Surgery, Diabetic Foot Unit, 222000La Paloma Hospital, Las Palmas de Gran Canaria, Spain.

Diabetic foot Unit, San Juan de Dios Hospital, San José de Costa Rica, Costa Rica.

出版信息

Int J Low Extrem Wounds. 2022 Dec;21(4):651-657. doi: 10.1177/15347346221116740. Epub 2022 Aug 4.

DOI:10.1177/15347346221116740
PMID:35924359
Abstract

We aimed to validate the value of adding osteomyelitis (OM) to moderate and severe categories of diabetic foot infections (DFIs) classification. We conducted a prospective study of a cohort of 200 patients with moderate and severe infections. Variables associated with prognosis were need for any amputation, major amputation, need for hospitalization, length of hospitalization, length of antibiotic therapy, reinfection rate and infection-related mortality. Infections were moderate in 111 cases (55.5%) and severe in 89 (44.5%). OM was diagnosed in 114 cases (57%), 73 presented as moderate (36.5%) and 41 as severe (20.5%). Overall, 129 patients (64.5%) were admitted for a median of 15 days (IQR 13) and 71 (35.5%) were treated as outpatients (day-surgery). Ninety-four patients (47%) were exclusively treated with intravenous antibiotics, 35 (17.5%) with intravenous and then shifting to oral, 16 (8%) exclusively with oral antibiotics, and 55 (27.5%) without antibiotics. Definitive surgery that led to the arrest of the infection was as follows: 117 patients (58.5%) underwent surgical debridement without amputation, and 69 (34.5%) underwent minor and 14 (7%) major amputation. Patients with OM presented as severe had a higher rate of amputations, major amputations, hospitalizations and need for antibiotic therapy when compared with OM presented as moderate. OM is strongly recommended to be added to the moderate and severe categories of the Infectious Diseases Society of America/International Working Group on Diabetic Foot severity system, as recommended by the International Working Group on Diabetic Foot 2019 guidelines.

摘要

我们旨在验证将骨髓炎(OM)纳入糖尿病足感染(DFI)中度和重度分类的价值。我们对 200 例中度和重度感染患者进行了前瞻性研究。与预后相关的变量包括任何截肢、大截肢、住院需要、住院时间、抗生素治疗时间、再感染率和感染相关死亡率。111 例(55.5%)感染为中度,89 例(44.5%)为重度。OM 诊断为 114 例(57%),73 例为中度(36.5%),41 例为重度(20.5%)。总体而言,129 例患者(64.5%)住院中位数为 15 天(IQR 13),71 例(35.5%)为门诊(日间手术)治疗。94 例患者(47%)仅接受静脉抗生素治疗,35 例(17.5%)先静脉后转为口服,16 例(8%)仅口服抗生素,55 例(27.5%)未用抗生素。导致感染停止的确定性手术如下:117 例患者(58.5%)行清创术无截肢,69 例(34.5%)行小截肢,14 例(7%)行大截肢。与 OM 中度表现相比,OM 重度表现患者的截肢率、大截肢率、住院率和抗生素治疗需求更高。国际糖尿病足工作组 2019 年指南建议,将骨髓炎强烈推荐纳入美国传染病学会/国际糖尿病足工作组糖尿病足严重程度系统的中度和重度类别。

相似文献

1
Prospective Validation of the Value of Adding Osteomyelitis to Moderate and Severe Categories of Diabetic Foot Infections.前瞻性验证将骨髓炎添加到糖尿病足感染的中度和重度类别中的价值。
Int J Low Extrem Wounds. 2022 Dec;21(4):651-657. doi: 10.1177/15347346221116740. Epub 2022 Aug 4.
2
Severe diabetic foot infections without systemic inflammatory response syndrome: Prospective validation of a new category.严重糖尿病足感染而无全身炎症反应综合征:新分类的前瞻性验证。
Wound Repair Regen. 2022 Sep;30(5):553-559. doi: 10.1111/wrr.13038. Epub 2022 Jul 30.
3
Surgical Diabetic Foot Infections: Is Osteomyelitis Associated With a Worse Prognosis?糖尿病足外科感染:骨髓炎是否与更差的预后相关?
Int J Low Extrem Wounds. 2023 Mar;22(1):36-43. doi: 10.1177/1534734620986695. Epub 2021 Feb 2.
4
Executive summary: 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections.执行摘要:2012 年美国传染病学会临床实践指南:糖尿病足感染的诊断与治疗。
Clin Infect Dis. 2012 Jun;54(12):1679-84. doi: 10.1093/cid/cis460.
5
2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections.2012 年美国传染病学会临床实践指南:糖尿病足感染的诊断与治疗。
Clin Infect Dis. 2012 Jun;54(12):e132-73. doi: 10.1093/cid/cis346.
6
The Infected Diabetic Foot: Re-evaluating the Infectious Diseases Society of America Diabetic Foot Infection Classification.感染性糖尿病足:重新评估美国感染病学会糖尿病足感染分类。
Clin Infect Dis. 2020 Apr 10;70(8):1573-1579. doi: 10.1093/cid/ciz489.
7
Clinical Outcomes of Foot Infections in Patients Without Diabetes.无糖尿病患者足部感染的临床转归。
J Foot Ankle Surg. 2020 Jul-Aug;59(4):722-725. doi: 10.1053/j.jfas.2019.07.026. Epub 2020 Feb 13.
8
Adjuvant antibiotic loaded bio composite in the management of diabetic foot osteomyelitis - A multicentre study.载抗生素生物复合材料辅助治疗糖尿病足骨髓炎——一项多中心研究
Foot (Edinb). 2019 Jun;39:22-27. doi: 10.1016/j.foot.2019.01.005. Epub 2019 Jan 11.
9
[Multidisciplinary management of diabetic foot ulcer infection].[糖尿病足溃疡感染的多学科管理]
Rev Med Interne. 2021 Mar;42(3):193-201. doi: 10.1016/j.revmed.2020.09.004. Epub 2021 Jan 12.
10
MRSA infection, re-infection and clinical outcomes in diabetic foot infections.耐甲氧西林金黄色葡萄球菌感染、再感染与糖尿病足感染的临床转归。
Wound Repair Regen. 2024 Jul-Aug;32(4):377-383. doi: 10.1111/wrr.13164. Epub 2024 Feb 28.

引用本文的文献

1
Re-infection after treatment for moderate and severe diabetic foot infections.治疗中重度糖尿病足感染后的再感染。
Int Wound J. 2024 Nov;21(11):e70123. doi: 10.1111/iwj.70123.